Bal Pharma is currently trading at Rs. 71.00, up by 3.40 points or 5.03% from its previous closing of Rs. 67.60 on the BSE.
The scrip opened at Rs. 67.50 and has touched a high and low of Rs. 70.00 and Rs. 66.50 respectively. So far 2,273 shares were traded on the counter.
The BSE group 'B ' stock of face value Rs. 10 has touched a 52 week high of Rs. 103.80 on 05-Nov-2014 and a 52 week low of Rs. 50.00 on 27-Mar-2015.
Last one week high and low of the scrip stood at Rs. 71.00 and Rs. 64.55 respectively. The current market cap of the company is Rs. 91.00 crore.
The promoters holding in the company stood at 48.83% while Institutions and Non-Institutions held 0.02% and 51.15% respectively.
Bal Pharma has launched its maiden over the counter (OTC) product ‘Eye Spa’ in Bangalore market. This is first among the series of OTC products that the company has lined up for launching in the market through its subsidiary i.e Lifezeh Healthcare. The company plans to roll out its products in other south Indian markets shortly, before their PAN India launch.
‘Eye Spa’ is a unique product which soothes and rejuvenates the tired eyes, due to their continuous exposure to dust, TV /computer screen , air conditioning and other modern lifestyle disorders.
Bal Pharma is in the business interest in area of manufacturing API, finished formulations, ayurvedic and research and development. It is one of the leading Indian pharmaceutical companies that focuses on prescription drugs, generic, OTC products, intravenous infusion and bulk actives.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1786.85 |
Dr. Reddys Lab | 1173.55 |
Cipla | 1525.50 |
Lupin | 2018.35 |
Zydus Lifesciences | 859.10 |
View more.. |